Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis-Reference-Cited by-同舟云学术

Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis

Published:2019-09-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Best Lawrence MJ¹,Freeman Suzanne C²,Sutton Alex J²,Cooper Nicola J²,Tng Eng-Loon³,Csenar Mario¹,Hawkins Neil⁴,Pavlov Chavdar S⁵⁶,Davidson Brian R¹,Thorburn Douglas⁷,Cowlin Maxine⁸,Milne Elisabeth Jane⁹,Tsochatzis Emmanuel⁷,Gurusamy Kurinchi Selvan¹⁶

Affiliation:

1. University College London; Division of Surgery and Interventional Science; Rowland Hill Street London UK NW32PF

2. University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH

3. Ng Teng Fong General Hospital National University Health System; Department of Medicine; 1 Jurong East Street 21 Singapore Singapore 609606

4. University of Glasgow; HEHTA; University Ave Glasgow G12 8QQ Glasgow UK

5. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

6. 'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\1 Moscow Russian Federation 119881

7. Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG

8. PSC Support; PO Box 6945 London UK

9. Coventry University; Centre for Trust, Peace and Social Relations; Coventry UK

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013103.pub2/epdf/full

Reference148 articles.

1. Noradrenaline vs terlipressin in hepatorenal syndrome: a prospective, randomized study;Alessandria;Journal of Hepatology,2006

2. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study;Alessandria;Journal of Hepatology,2007

3. Terlipressin is superior to Noradrenaline in the management of acute kidney injury (AKI) in patients with ACLF;Arora;Journal of Hepatology,2017

4. Terlipressin is superior to noradrenaline in management of acute kidney injury in acute on chronic liver failure;Arora;Indian Journal of Gastroenterology,2017

5. Arora V Maiwall R Vijayaraghavan R Jindal A Saggere Muralikrishna S Kumar G Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure Hepatology 10.1002/hep.30208

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile;Gastroenterology Insights;2023-09-28

2. Management of Portal Hypertension in Patients with Acute-on-Chronic Liver Disease;Clinics in Liver Disease;2023-08

3. Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study;JGH Open;2023-07-27

4. Recent advances in pathophysiology, diagnosis and management of hepatorenal syndrome: A review;World Journal of Hepatology;2023-06-27

5. Management of the acute on chronic liver failure in the intensive care unit;Liver International;2023-06-27